Skip to main content
Caplight Logo









Fyodor Biotechnologies

Fyodor Biotechnologies

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://fyodorbio.com/

Last Round

Grant

Sep 24, 2012

Total Funding Raised

$2.13M

Company Overview

Fyodor Biotechnologies is a biotechnology company that develops and commercializes innovative, non-invasive diagnostic products for global health diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

malaria diagnosticpoint-of-care testingPOCTurine malaria testUMTrapid diagnostic testRDTnon-invasive diagnosticslateral flow assaydipstick testglobal health diagnosticsmedical device manufacturerresource-limited diagnosticslow-cost healthcareinfectious disease testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fyodor Biotechnologies Comparables

Compare Fyodor Biotechnologies with similar companies based on industry and business-model similarity.

Fyodor Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Erada Technology Alliance
85%
Premier Medical Corporation
82%
Hemex Health
78%

Fyodor Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 24, 2012
GrantAug 22, 2012

Fyodor Biotechnologies Investors

Notable investors and investment history

Fyodor Biotechnologies investors
InvestorRounds
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Monthly visitors grew 58% MoM, reaching 1.5K.

  • Aug 22, 2012

    $150K grant from the National Science Foundation.

Fyodor Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Fyodor Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fyodor Biotechnologies's valuation, stock price, and market status.

Is Fyodor Biotechnologies a public or private company?

Fyodor Biotechnologies is a private company.

What is the current stock price of Fyodor Biotechnologies?

Fyodor Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is Fyodor Biotechnologies worth (valuation)?

Valuation information for Fyodor Biotechnologies is not publicly available.

Can I buy Fyodor Biotechnologies stock?

Fyodor Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fyodor Biotechnologies's last funding round?

Fyodor Biotechnologies's most recent funding round was Grant on September 24, 2012.

Who are the main investors in Fyodor Biotechnologies?

Key investors in Fyodor Biotechnologies include National Science Foundation.

Will Fyodor Biotechnologies IPO soon?

No public IPO plans have been announced for Fyodor Biotechnologies.

How can I track Fyodor Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fyodor Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range4
Year Founded2008
Last FundingSep 24, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?